Risks of contraception: vascular diseases
Genz, H.J.; Ludwig, H.
Therapeutische Umschau. Revue Therapeutique 43(5): 388-391
1986
ISSN/ISBN: 0040-5930 PMID: 3726774 Document Number: 269456
Document emailed within 1 workday
Related Documents
Monier, L. 1988: Risques métaboliques de la contraception orale - Metabolic risks of contraception in teenagers Revue Internationale de Pediatrie (178): 64-65Batur, P.; Sikka, S.; McNamara, M. 2018: Contraception Update: Extended Use of Long Acting Methods, Hormonal Contraception Risks, and Over the Counter Access Journal of Women's Health 27(12): 1437-1440
Batur, P.; Sikka, S.; McNamara, M. 2018: Contraception Update: Extended Use of Long Acting Methods, Hormonal Contraception Risks, and Over the Counter Access Journal of Women's Health 27(12): 1437-1440
Chanu, B. 1993: Combined oral estrogen / progestin contraception: practical attitude. Vascular attacks and contraception Arteres et Veines 12(3): 176-179
Chanu, B. 1993: Combined oral estrogen / progestin contraception: practical attitude. Vascular attacks and contraception Arteres et Veines 12(3): 176-179
Pelissier, C.; Basdevant, A.; Conard, J.; Egloff, M.; Husson, T.; Guyenne, T.T. 1987: Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study) Contraception Fertilite Sexualite 15(1): 45-54
Ishioka, S.; Maeda, A.; Hiyama, K.; Yamakido, M. 1995: Pulmonary manifestation of collagen vascular diseases: role of cytokines in interstitial pneumonia associated with collagen vascular diseases Nihon Kyobu Shikkan Gakkai Zasshi 33 Suppl: 277-283
Zufferey, M.M. 1984: Risks of new contraception methods Gynakologische Rundschau 24(Suppl 1): 40-42
McEwan, J. 1979: The risks of oral contraception British Journal of Hospital Medicine 21(2): 144; 146 148-150
Iffy, L. 1979: Risks associated with the rhythm method of contraception Contraception Fertilite Sexualite 7(7): 505-509
Foussard-blanpin, O.; Paillot-renaud, P.; Bruneau-bigot, A. 1984: Oral contraception: failures and risks Lyon Pharmaceutique 35(6): 385-393
Haider, Z.; D'Souza, R. 2009: Non-contraceptive benefits and risks of contraception Best Practice and Research. Clinical Obstetrics and Gynaecology 23(2): 249-262
Welti, H. 1986: Risks of contraception using intrauterine devices Therapeutische Umschau. Revue Therapeutique 43(5): 400-403
Serfaty, D. 1988: Contraception et maladies sexuelles transmissibles - Contraception and sexually transmitted diseases Contraception Fertilite Sexualite (1973) 16(11): 927-934
Jobin, F. 1976: Blood platelets and cardiovascular diseases. III. Diseases with increased platelet consumption and vascular diseases L'Union Medicale du Canada 105(5): 756-766
Alouini, S.; Venslauskaite, G.; Lubarskiene, Z. 2015: Contraception with levonorgestrel system and risks of breast cancer American Journal of Obstetrics and Gynecology 212(2): 255
Courtieu, C.; Marès, P. 1992: Contraception. Methods, efficacy, choice, contraindications, monitoring, risks La Revue du Praticien 42(17): 2223-2234
Nau, J.-Y. 2006: New warnings on the pathologic vascular risks associated with NSAIDs Revue Medicale Suisse 2(82): 2313
Silvestrini, P.; Raso, A.M. 1972: Peridural anesthesia in vascular surgery. I. use of it in surgical treatment of peripheral vascular diseases Chirurgia 21(7): 651-657
Baeten, J.M.; Heffron, R. 2015: Contraception and sexually transmitted infections: risks and benefits, hypotheses and evidence Lancet. Global Health 3(8): E430-E431